Atricure Inc. buy JPMorgan Chase & Co.
Start price
16.12.25
/
50%
€34.60
Target price
16.12.26
€40.85
Performance (%)
-8.09%
Price
09:04
?
Summary
This prediction is currently active. With a performance of -8.09%, the BUY prediction for Atricure Inc. by JPMorgan_Chase___Co_ is down slightly. This prediction currently runs until 16.12.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Atricure Inc. | -3.750% | -3.750% |
| iShares Core DAX® | -0.559% | 0.738% |
| iShares Nasdaq 100 | -0.566% | -0.324% |
| iShares Nikkei 225® | 1.073% | 5.624% |
| iShares S&P 500 | 0.868% | 0.030% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Atricure Inc. diskutieren
AtriCure (NASDAQ:ATRC) had its price target raised by analysts at JPMorgan Chase & Co. from $42.00 to $48.00. They now have an "overweight" rating on the stock.
Ratings data for ATRC provided by MarketBeat

